High-definition DNA methylation profiles from breast and ovarian carcinoma cell lines with differing doxorubicin resistance.
Acquired drug resistance represents a frequent obstacle which hampers efficient chemotherapy of cancers. The contribution of aberrant DNA methylation to the development of drug resistant tumor cells has gained increasing attention over the past decades. Hence, the objective of the presented study wa...
Guardado en:
Autores principales: | Michael Boettcher, Frank Kischkel, Jörg D Hoheisel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/95f8873783c34a0eacea5496ce3540d7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
DNA methylation and Transcriptome Changes Associated with Cisplatin Resistance in Ovarian Cancer
por: Riikka J. Lund, et al.
Publicado: (2017) -
Global analysis of DNA methylation by Methyl-Capture sequencing reveals epigenetic control of cisplatin resistance in ovarian cancer cell.
por: Wei Yu, et al.
Publicado: (2011) -
Nongenotoxic ABCB1 activator tetraphenylphosphonium can contribute to doxorubicin resistance in MX-1 breast cancer cell line
por: Raimonda Kubiliute, et al.
Publicado: (2021) -
Sarcoma classification by DNA methylation profiling
por: Christian Koelsche, et al.
Publicado: (2021) -
Chitosan-Dextran sulfate coated doxorubicin loaded PLGA-PVA-nanoparticles caused apoptosis in doxorubicin resistance breast cancer cells through induction of DNA damage
por: Sumit Siddharth, et al.
Publicado: (2017)